Emergent BioSolutions Files 8-K
Ticker: EBS · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
TL;DR
Emergent BioSolutions dropped an 8-K on March 10th – check for updates.
AI Summary
Emergent BioSolutions Inc. filed an 8-K on March 10, 2025, to report on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company's principal executive offices are located at 300 Professional Drive, Gaithersburg, Maryland.
Why It Matters
This 8-K filing provides important updates and disclosures from Emergent BioSolutions Inc. to the public and its investors.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to contain significant negative news or events.
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Registrant
- March 10, 2025 (date) — Date of earliest event reported
- 300 Professional Drive, Gaithersburg, Maryland 20879 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Emergent BioSolutions Inc.?
The 8-K filing serves to report on various events including Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, as of March 10, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 10, 2025.
Where are Emergent BioSolutions Inc.'s principal executive offices located?
Emergent BioSolutions Inc.'s principal executive offices are located at 300 Professional Drive, Gaithersburg, Maryland 20879.
What is the SEC file number for Emergent BioSolutions Inc.?
The SEC file number for Emergent BioSolutions Inc. is 001-33137.
What is the IRS Employer Identification Number for Emergent BioSolutions Inc.?
The IRS Employer Identification Number for Emergent BioSolutions Inc. is 14-1902018.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Emergent BioSolutions Inc. (EBS).